Page last updated: 2024-10-30

methazolamide and Ankylosing Spondylarthritis

methazolamide has been researched along with Ankylosing Spondylarthritis in 2 studies

Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.

Research Excerpts

ExcerptRelevanceReference
"Methazolamide is a carbonic anhydrase (CA) inhibitor with satisfactory safety."1.91Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA. ( Gao, P; Liang, W; Liu, Q; Sun, T; Wang, M; Yan, X, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sun, T1
Wang, M1
Liang, W1
Gao, P1
Liu, Q1
Yan, X2
Chang, X1
Zhang, Y1

Other Studies

2 other studies available for methazolamide and Ankylosing Spondylarthritis

ArticleYear
Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA.
    Scientific reports, 2023, 09-16, Volume: 13, Issue:1

    Topics: Carbonic Anhydrase Inhibitors; Humans; Methazolamide; Molecular Docking Simulation; Network Pharmaco

2023
Treat ankylosing spondylitis with methazolamide.
    International journal of medical sciences, 2011, Volume: 8, Issue:5

    Topics: Administration, Oral; Carbonic Anhydrase Inhibitors; Humans; Methazolamide; Spondylitis, Ankylosing

2011